INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Corporate insider
SM

Schlosser Mario

Director, President of Technology & CTOCIK 0001844320

EDGAR filingsOpen in network
Disclosed transactions54
Buys / sells0 / 23
Max Insider Score48
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SM
Schlosser MarioDirector
DUOLDuolingo, Inc.
Grant or award
A$17K
116 sh
Oct 10, 2026Oct 13, 2026
traded Oct 10, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Duolingo, Inc.Director · Oct 13, 2026
  • Insider ofevidence
    Oscar Health, Inc.Director, President of Technology & CTO · Nov 13, 2025
24
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL
$988K
31.4K sh
Sep 3, 2026
Sep 8, 2026
traded Sep 3, 2026
+5d
SEC FORM 4

Evidence

14
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

41
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$4.62M
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

19
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M$5.85M
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

14
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

6
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

15
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M$1.46M
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

6
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

48
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$18.20M
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
47.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
47.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

15
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$8.31M
287.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

22
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$17.49M
591.2K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

1
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
1,799 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$994K
33.6K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$994K
33.6K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
15.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$944K
31.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2,919
97 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise · 10b5-1 plan
M—
660.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise · 10b5-1 plan
M$6.43M
660.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

19
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$532K
24.5K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
9,668 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

11
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

3
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

14
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

17
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$583K
38.8K sh
Dec 24, 2025Dec 30, 2025
traded Dec 24, 2025
+6dSEC FORM 4

Evidence

22
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$398K
24.0K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

13
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
105.3K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

38
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale
SELL$4.37M
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

9
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Option exercise
M—
413.8K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

21
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

26
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Option exercise
M$2.63M
413.8K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

17
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

5
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Option exercise
M—
141.3K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

15
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Option exercise
M$899K
141.3K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

9
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
105.3K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

30
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale
SELL$1.58M
105.3K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence